This study involved the extensive use of both primary and
secondary sources. The research process involved the study of various factors
affecting the industry to identify the segmentation types, industry trends, key
players, competitive landscape, key market dynamics, and key player strategies.
Objectives of
the Study:
# To define, describe, segment, and forecast the global
proteomics market by instrumentation technology, reagent, services and
software, application, end user, and region.
# To provide detailed information about the factors
influencing market growth (such as drivers, restraints, opportunities, and
industry-specific challenges)
# To analyze micromarkets with respect to individual growth
trends, prospects, and contributions to the overall market
# To analyze market opportunities for stakeholders and
provide details of the competitive landscape for key players
# To forecast the size of the proteomics market in five main
regions along with their respective key countries (North America, Europe, Asia
Pacific, Latin America, and the Middle East & Africa)
# To profile key players in the global proteomics market and
comprehensively analyze their core competencies and market shares
# To track and analyze competitive developments such as
acquisitions; product launches; expansions; collaborations, partnerships, &
agreements; and R&D activities of the leading players in the proteomics
market
Looking Out for
More Details | Don’t Hesitate to Download the PDF
Brochure@
Recent
Developments:
# In 2018, Thermo Fisher Scientific, Inc. and Symphogen
formed a collaboration under which Symphogen will use the Thermo Scientific Q
Exactive Plus Orbitrap LC/MS/MS system with its BioPharma Option to create,
test, and validate platform workflows for intact and native mass analysis of
therapeutic monoclonal antibody (mAb) mixtures.
# In 2018, Thermo Fisher Scientific, Inc. launched TSQ
Fortis Triple Quadrupole Mass Spectrometer and UHPLC-MS Ultrapure Solvents.
# In 2018, Agilent Technologies acquired Advanced Analytical
Technologies, Inc. to enhance its technology base and provide a comprehensive
set of solutions for NGS workflows.
# In 2017, Merck KGaA signed an MoU with Samsung BioLogics
for a strategic alliance on biopharmaceutical manufacturing and biologics
process development. Under the agreement, Merck would supply Mobius single-use
systems, cell line, cell culture media, and chromatography to accelerate the
development of biologic drugs.
Critical
questions answered in the report:
# How will the current technological trends affect the
proteomics market in the long term?
# How is the service market for proteomics moving?
# What are the application areas of the market?
# Which regions are likely to grow at the highest CAGR?
# What are the growth strategies being implemented by major
market players?
Factors
Influencing Global Industry Growth:-
Growth in this market is driven by increasing research
activity in the area of personalized medicine and drug discovery, increasing
R&D expenditure by the pharmaceutical and biotechnology sector, and rising
government funding for proteomics.
Restraints:
# High Cost of Instruments
Key
Market Opportunities:
# Growing Prominence of Nanoproteomics - the
Convergence of Nanotechnology and Proteomics
# Personalized Proteomics for Precision Health
# High Growth Opportunities in Emerging
Countries
Challenges:
# Data Management in Proteomics Research
# Low Biomarker Discovery-To-Approval Ratio
Industry’s
Revenue Growth Expectations:
The proteomics market is projected to reach USD
38.7 billion by 2024 from USD 19.5 billion in 2019, at a CAGR of 14.7%.
Geographical Growth Scenario:
In 2018, North America dominated the global proteomics
market, followed by Europe. Increasing investments in the development of
structure-based drug designs, growing academic and government investments in
genomics and proteomics research, rising demand for high-quality research tools
for data reproducibility, and rising focus of stakeholders on research projects
involving proteins, associated biomolecules, and genes are the factors
propelling the growth of the market in the region.
Leading Market
Players:
# Thermo Fisher Scientific, Inc. (US)
# Agilent Technologies, Inc. (US)
# GE Healthcare (US)
# Bio-Rad Laboratories, Inc. (US)
# Danaher Corporation (US)
# Luminex
Corporation (US) and
many more…
No comments:
Post a Comment